A 63-year-old male on increased phenytoin (200 mg morning, 300 mg evening) with a subtherapeutic phenytoin level, who just completed levofloxacin (750 mg daily for 7 days), now presents with severe abdominal pain, nausea, headache, and melena after constipation—does he have an upper gastrointestinal bleed and what is the appropriate management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Hospital Transfer for Suspected Upper GI Bleed with Urgent Endoscopy

This patient requires immediate hospital admission for suspected upper gastrointestinal bleeding with urgent endoscopy within 24 hours, hemodynamic assessment, resuscitation, and high-dose intravenous proton pump inhibitor therapy. The combination of melena (black stools), severe abdominal pain (8/10), nausea, headache, and a subtherapeutic phenytoin level in a 63-year-old male strongly suggests an acute upper GI bleed, likely peptic ulcer disease.

Clinical Assessment and Risk Stratification

Melena following constipation is a classic presentation of upper gastrointestinal bleeding and requires urgent evaluation 1. The patient's age (63 years), severe abdominal pain, and recent antibiotic use place him at significant risk 1.

Immediate Actions Required:

  • Assess hemodynamic status immediately: Check vital signs for shock (pulse >100 bpm, systolic BP <100 mmHg) 1
  • Calculate shock index (heart rate/systolic BP): If >1, this indicates hemodynamic instability requiring aggressive resuscitation 1
  • Obtain complete blood count: Check hemoglobin to assess degree of blood loss 1
  • Establish IV access and initiate crystalloid resuscitation if hemodynamically unstable 1

Resuscitation and Initial Management

Use restrictive transfusion thresholds: Transfuse red blood cells if hemoglobin <70 g/L (target 70-90 g/L), or <80 g/L if cardiovascular disease is present (target up to 100 g/L) 1.

Initiate high-dose intravenous PPI immediately before endoscopy: 80 mg IV bolus followed by continuous infusion at 8 mg/hour 1, 2. This should not delay endoscopy but improves outcomes in patients with peptic ulcer bleeding 1.

Administer erythromycin 250 mg IV 30-120 minutes before endoscopy to improve visualization, particularly given the clinical severity 2, 1.

Endoscopic Evaluation

Perform upper endoscopy within 24 hours of presentation 1. Given his severe symptoms and melena, consider earlier endoscopy (within 12 hours) if hemodynamic instability persists despite resuscitation 1, 2.

Endoscopic Therapy Indications:

Endoscopic hemostasis is indicated for high-risk lesions 1, 2:

  • Active spurting or oozing bleeding (Forrest Ia, Ib)
  • Non-bleeding visible vessel (Forrest IIa)
  • Adherent clot (Forrest IIb) after clot removal

Recommended endoscopic techniques: Combination therapy (epinephrine injection plus thermal coagulation or clips) is superior to monotherapy 1, 2.

Post-Endoscopy Management

Continue high-dose IV PPI (80 mg bolus then 8 mg/hour infusion) for 72 hours after successful endoscopic hemostasis 1, 2.

Transition to oral PPI: After 3 days of IV therapy, switch to oral PPI twice daily for 14 days, then once daily 1, 2.

The Levofloxacin Connection

Levofloxacin does not directly cause GI bleeding but can cause severe gastrointestinal adverse effects including nausea and abdominal pain 3. However, fluoroquinolones are not listed among the primary drug classes causing GI bleeding (NSAIDs, antiplatelet agents, anticoagulants) 4, 5.

The timing is likely coincidental: His symptoms began while on levofloxacin, but the melena and severe pain are more consistent with peptic ulcer disease, possibly exacerbated by stress from recent seizures and hospitalization 4, 5.

The Subtherapeutic Phenytoin Level

Address the subtherapeutic phenytoin level (5.4) after stabilizing the GI bleed. This requires:

  • Verification of medication adherence
  • Assessment for drug interactions or malabsorption
  • Possible dose adjustment once acute illness resolves
  • The GI bleeding itself may impair absorption

Do not adjust phenytoin during acute bleeding as hemodynamic instability and altered absorption will affect levels.

Critical Pitfalls to Avoid

Do not discharge this patient: Melena with severe abdominal pain requires inpatient evaluation regardless of hemodynamic stability 1.

Do not delay endoscopy for complete hemodynamic stabilization if the patient remains unstable—early endoscopy (within 12 hours) may be lifesaving 1, 2.

Do not use H2-receptor antagonists: They are inferior to PPIs and not recommended 1.

Do not perform routine second-look endoscopy: Only repeat if clinical evidence of rebleeding occurs 1, 2.

Testing for Helicobacter pylori

Test for H. pylori during acute presentation and initiate eradication therapy if positive 1, 2. Retest if initially negative, as acute bleeding can cause false negatives 2.

Monitoring for Rebleeding

Clinical signs of rebleeding include: hematemesis, ongoing melena, hemodynamic instability, or drop in hemoglobin >20 g/L over 24 hours 1.

If rebleeding occurs: Repeat endoscopy with hemostasis; if second attempt fails, consider transcatheter angiographic embolization or surgery 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.